Abbott India Limited vs Global Health Limited (Medanta)
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Global Health Limited (Medanta) (Healthcare services / hospitals) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Head-to-head highlights
| Metric | Abbott India Limited | Global Health Limited (Medanta) | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately INR 3,200-3,400 crore, unverified rough range | AI estimate |
| Net profit (approx.) | INR 1,100-1,300 crore | Approximately INR 450-500 crore, unverified rough range | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Global Health Limited (Medanta)
Healthcare services / hospitals · India
Medanta is a major Indian hospital group operated by Global Health Limited, providing multi-specialty tertiary and quaternary healthcare services. It is best known for Medanta - The Medicity in Gurugram and operates hospitals across several Indian cities.
Verified financials
No source-verified financials available.
Strengths
- Strong clinical reputation in tertiary and quaternary care
- Established flagship hospital in Gurugram
- Experienced specialist doctors and high-acuity capabilities
- Recognized premium healthcare brand
Weaknesses
- Smaller hospital network than some national competitors
- High dependence on specialist talent and flagship facilities
- Capital-intensive expansion model
- Exposure to pricing sensitivity in Indian healthcare
Opportunities
- Expansion into underserved tier-1 and tier-2 Indian cities
- Growth in medical tourism and international patient volumes
- Rising demand for oncology, cardiac, and chronic disease care
- Digital health and integrated outpatient services
Threats
- Competition from larger hospital chains
- Regulatory scrutiny on healthcare pricing and quality
- Doctor attrition and talent competition
- Macroeconomic pressure affecting discretionary healthcare spending
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Global Health Limited (Medanta): which company leads overall?
Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
Global Radiopharmaceuticals and Theranostics Market — Intelligence Report
Global GLP-1 Obesity Drugs, Oral Incretins and Metabolic Health Services Market — Intelligence Report
Global Digital Health & Telemedicine Market — Intelligence Report
Global Precision Medicine & Genomics Market — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Global Health Limited (Medanta)'s verified data. Modeled estimates — not investment advice.
Not enough data yet to generate insights.